Jan 6, 2014 ... Microbix Biosystems Inc. alleges that Switzerland-based Novartis Vaccines and Diagnostics Inc. misappropriated Microbix's methodology for upping virus yields during the ... The case is Microbix Biosystems Inc. v. Novartis ...
May 15, 2015 ... TORONTO, May 15, 2015 – Microbix Biosystems Inc. (TSX: MBX) (“Microbix” ... has provided its decisions on a litigation between Microbix and Novartis. ... namely in the vaccine, therapeutic and diagnostic markets, as well as ...
Mar 26, 2015 ... Microbix Biosystems Inc. ... VIRUSMAX® patent infringement lawsuit against Novartis Vaccines and Diagnostics ("Novartis") without prejudice.
Investors are always looking for growth in small-cap stocks like Microbix Biosystems Inc (TSX:MBX), with a market cap of CAD CA$28.38M. However, ...
Shire Orphan Therapies LLC et al v. Fresenius Kabi USA, LLC, No. 1:15cv01102 (D.Del.) Supernus Pharmaceuticals, Inc. v. TWI Pharmaceuticals, Inc. et al, No.
Jun 6, 2015 ... have emerged globally: Microbix Biosystems v. Novartis Vaccines and Diagnostics2, related to. Microbix's Virusmax ... 201. 5. Nature. America, Inc. All rights reserved. ..... Diagnostics, 6:14-cv-00003, No. 76 (E.D. Tex. Feb.
Apr 23, 2016 ... ... human CMV grade 2 antigen (100 µg/mL; Microbix Biosystems Inc., Mississauga, ON ..... and personal compensations from TEVA and Novartis. .... Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. ... of the human memory B-cell repertoire following infection and vaccination.
Feb 3, 2011 ... Translational Medicine, Novartis Vaccines and Diagnostic, Italy ... to opportunistic pathogens and did not weaken the Graft vs ..... and ADV antigens are from Microbix Biosystems Inc., (Toronto, Canada) as full proteins.
He has won high-profile bet-the-company cases involving claims for breach of contract, fraud, trade secret theft, patent and trademark infringement, ...